Publications by authors named "Gerald A Faich"
Cardiac safety of diabetes therapies and postmarketing requirements.
Pharmacoepidemiol Drug Saf
August 2008
Background: Ziprasidone has been used to treat schizophrenia since 2000. It is unknown whether its modest QTc-prolonging effect increases cardiovascular event risk.
Purpose: To describe the study design of the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC).
Background: Moxifloxacin is an advanced-generation fluoroquinolone used primarily for the treatment of respiratory tract infections.
Objective: To further investigate moxifloxacin's general and cardiac safety and evaluate its efficacy in the community practice setting in a large surveillance study.
Methods: A total of 18,409 outpatients with suspected bacterial episodes of acute sinusitis, acute exacerbation of chronic bronchitis, or community-acquired pneumonia of mild to moderate severity were enrolled at 3377 community practice sites.